🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.

Service Reaction and Content Removal

According to the social media company, the service has taken down violative material and banned associated hashtags and search suggestions. The organization stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Investigations also found communities with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.

Within moments of joining one community, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Product Details and Pricing

Within these communities, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already seen individuals injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental substance not yet approved … may subject patients to possibly serious health risks”.